Sharon Bio-Medicine Ltd-$ (Delisted) share price history
BSE: 532908Pharmaceuticals & Biotechnology
Last traded ₹3.30 on 28 Mar 2019
Delisted on 20 Feb 2024.
Last announcements
The company's own last announcements before its shares stopped trading, routine notices left out.Share news and announcements
Feb 2024
14 Feb · Delisting
Members of the Exchange are hereby informed that the admission to dealings in securities of Sharon Bio-Medicine Limited shall be withdrawn (delisted) w.e.f. February 20, 2024 pursuant to the Resolution Plan approved by the Hon'ble Mumbai Bench of National Company Law Tribunal (NCLT) under Section 31 of the Insolvency and Bankruptcy Code (IBC), 2016.
Aug 2023
Jun 2023
30 Jun · Corporate Insolvency Resolution Process
30 Jun · Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
16 Jun · Legal
Exchange has sought clarification from Sharon Bio-Medicine Limited for the quarter ended 31-Mar-2023 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results not signed by authorized signatory/ies -2. The company has not submitted the Statement of Modified Opinion or in case of unmodified opinion(s), a declaration to that effect to the Stock Exchange. The response of the Company is awaited.8 Jun · Suspension of Trading
Members of the Exchange are hereby informed that the trading in equity shares of Sharon Bio-Medicine Limited (ISIN: INE028B01029) shall continue to be suspended pursuant to order dated May 17, 2023 passed by National Company Law Tribunal.
Results
Standalone; ₹ crore, the charts by years to June, then March, the table by quarter.Quarterly results
Quarter to Mar 2023, against the quarter beforeFiled 30 May
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹44 Crdown 23.39%
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹1.81 Crdown 80.93%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- 4.1%
Revenue by year
Net profit by year, a loss in red
- Net profit
- Loss
The company moved its year end from June to March: its last year to June on record ended in Jun 2015, its first year to March in Mar 2017. The 9 months to Mar 2016 between them are one changeover period, not a year, and the yearly charts leave it out.
| ₹ crore | Jun 2021Filed 17 Aug | Sep 2021Filed 4 Nov | Dec 2021Filed 7 Feb | Mar 2022Filed 23 May | Jun 2022Filed 6 Sep | Sep 2022Filed 23 Nov | Dec 2022Filed 10 Feb | Mar 2023Filed 30 May |
|---|---|---|---|---|---|---|---|---|
| Revenue | 48.9 | 45.4 | 44.4 | 49.8 | 37.8 | 55.2 | 57.7 | 44.2 |
| Net profit | 4.5 | 4.5 | 4.0 | 4.7 | −1.1 | 8.8 | 9.5 | 1.8 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 9.2% | 9.9% | 9.1% | 9.4% | −2.9% | 16.0% | 16.4% | 4.1% |
Business segments
In the year to Mar 2023 the company reports one business segment, PHARMACEUTICALS, which carries all its revenue.
Sharon Bio-Medicine Ltd-$ share price by year
Each calendar year to 2019.
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2019 | 3.30 | −34.7% | 5.05 | 3.10 |
| 2018 | 5.05 | −31.3% | 9.75 | 2.85 |
| 2017 | 7.35 | −21.0% | 9.60 | 5.10 |
| 2016 | 9.30 | −66.4% | 28.90 | 8.35 |
| 2015 | 27.70 | −17.8% | 39.95 | 12.60 |
Recent sessions
The last 10 trading days to 28 Mar 2019, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 28 Mar 2019 | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 | 8,834 |
| 27 Mar 2019 | 3.50 | 3.50 | 3.45 | 3.45 | 3.45 | 13,863 |
| 26 Mar 2019 | 3.75 | 3.75 | 3.60 | 3.60 | 3.60 | 7,580 |
| 25 Mar 2019 | 3.75 | 3.75 | 3.70 | 3.75 | 3.72 | 1,589 |
| 22 Mar 2019 | 3.85 | 4.00 | 3.85 | 3.85 | 3.85 | 28,344 |
| 20 Mar 2019 | 4.45 | 4.45 | 4.05 | 4.05 | 4.16 | 44,575 |
| 19 Mar 2019 | 4.50 | 4.50 | 4.15 | 4.25 | 4.27 | 20,506 |
| 18 Mar 2019 | 4.50 | 4.50 | 4.10 | 4.35 | 4.37 | 25,819 |
| 15 Mar 2019 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 9,861 |
| 14 Mar 2019 | 4.10 | 4.10 | 4.10 | 4.10 | 4.10 | 7,820 |
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 15 Dec 2014 | Price move | – | Between two trading sessions the price moved by a fifth or more. No corporate action is on record. Not adjusted for. |
| 20 Feb 2014 | Price move | – | Between two trading sessions the price fell 47% or more, or rose 90% or more. No corporate action is on record. Earlier prices are not shown. |
Company details
- Legal name
- SHARON BIO-MEDICINE LTD.
- BSE code
- 532908
- ISIN
- INE028B01029
- Industry
- Pharmaceuticals & Biotechnology
- Listed
- Oct 2007
- Face value
- ₹2
- Former symbols
- SHARONBIO
- CIN
- L24110MH1989PLC052251
- Corporate identity number, the registrar of companies' code for it